Company Information
USD
17.41
- (0.9%)
NASDAQ:BEAM, BEAM THERAPEUTICS INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
Address
238 Main Street
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Graham K. Cooper
Director
Dr. John M. Maraganore,PhD
Director
Mr. Mark C. Fishman,M.D.
Director
Ms. Kristina M. Burow
Director
Ms. Kathleen E. Walsh
Director
Ms. Christi Shaw
Director
Dr. Carole Ho, M.D.
Director
Mr. John Evans
CEO/Director
Ms. Terry-Ann Burrell
CFO/Chief Accounting Officer/Treasurer
Dr. Giuseppe Ciaramella
President
Dr. Christine Bellon, PhD
Chief Legal Officer/Secretary
Dr. Amy Simon, M.D.
Chief Medical Officer
Ownership
Institution Holdings
ARK Investment Management LLC
9,393,889 (11.504%)
FMR LLC
7,769,016 (9.514%)
Vanguard Group Inc
7,164,876 (8.774%)
BlackRock Inc
6,662,043 (8.159%)
FMR Inc
6,180,322 (7.569%)
State Street Corporation
4,616,358 (5.653%)
Morgan Stanley - Brokerage Accounts
4,184,342 (5.124%)
Farallon Capital Management, L.L.C.
4,105,753 (5.028%)
BlackRock Fund Advisors
3,263,016 (3.996%)
SSGA Funds Management Inc
3,247,950 (3.978%)
Individual Holdings
Mr. John Evans
1,058,262 (1.298%)
Dr. Giuseppe Ciaramella
139,150 (0.175%)
Dr. Christine Bellon, PhD
80,495 (0.099%)
Dr. Amy Simon, M.D.
65,469 (0.081%)
Ms. Terry-Ann Burrell
47,117 (0.063%)
Mr. Mark C. Fishman,M.D.
17,007 (0.034%)
Ms. Kristina M. Burow
26,011 (0.034%)
Funds Holdings
ARK Disruptive Innovation Full Composite
6,432,811 (7.878%)
ARK Innovation ETF
5,852,105 (7.167%)
SPDR® S&P Biotech ETF
3,189,956 (3.907%)
ARK Genomic Revolution
2,574,870 (3.153%)
Vanguard Total Stock Market Index Fund
2,307,914 (2.826%)
Vanguard US Total Market Shares ETF
2,307,914 (2.826%)
ARK Genomic Revolution ETF
2,258,927 (2.766%)
Vanguard Small Cap Index
1,873,204 (2.294%)
iShares Russell 2000 ETF
1,777,419 (2.177%)
Nikko AM ARK Disruptive Innovation Fund
1,202,271 (1.472%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
